1Eden Estevez, 2Shivaughn M. Hem-Lee-Forsyth, 3N'Diera Viechweg, 4Sharon John, 5Stephanie P. Menor
1,2,3,4,5St. George's University, St. George's, Grenada.
DOI : https://doi.org/10.47191/ijmra/v7-i05-17Google Scholar Download Pdf
ABSTRACT:
The discomfort and apprehension associated with the Intrauterine Device (IUD) insertion procedure presents a challenge to its widespread acceptance as a contraceptive modality, notwithstanding its established efficacy. Healthcare providers play a pivotal role in addressing this challenge through the provision of comprehensive educational interventions targeting young women regarding the intricacies of IUD insertion. Such proactive educational endeavors hold promise in fostering heightened acceptance and utilization of the IUD, thereby reducing the rates of unintended pregnancies. This paper delineates strategic interventions aimed at fostering IUD adoption, bolstered by empirical evidence attesting to its efficacy in curbing rates of unplanned pregnancies, childbirths, and induced abortions, particularly within the demographic of young women.
REFERENCES
1) Akdemir Y, Karadeniz M. The relationship between pain at IUD insertion and negative perceptions, anxiety, and previous mode of delivery. The European Journal of Contraception & Reproductive Health Care. 2019;24(3):240-245. doi:https://doi.org/10.1080/13625187.2019.1610872.
2) American College of Obstetrics and Gynecology. Long-Acting Reversible Contraception: Implants and Intrauterine Devices. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2017/11/long-acting-reversible-contraception-implants-and-intrauterine-devices. Accessed February 14, 2024.
3) Bahamondes MV, Bahamondes L. Intrauterine device use is safe among nulligravidas and adolescent girls. Acta Obstetricia et Gynecologica Scandinavica. 2021;100(4):641-648. doi:https://doi.org/10.1111/aogs.14097.
4) Centers for Disease Control and Prevention.
Intrauterine Contraception. https://www.
cdc.gov/reproductivehealth/contraception/mmwr/spr/intrauterine.
html#:~:text=IUDs%20are%20long%2Dacting%2C%20are.
January 16, 2019. Accessed March 19, 2024.
5) Chelvakumar M, Jabbarpour Y, Coffman M, Jetty A, Glazer Shaw J. Long-acting Reversible Contraception (LARC) Provision by Family Physicians: Low But on the Rise. The Journal of the American Board of Family Medicine. 2019;32(1):10-12. doi:https://doi.org/10.3122/jabfm.2019.01.180215.
6) Committee Opinion No. 615. Obstetrics & Gynecology. 2015;125(1):250-255. doi:https://doi.org/10.1097/01.aog.0000459866.14114.33.
7) Gatz JL, Mary Anne Armstrong, Postlethwaite D, et al. Association between intrauterine device type and risk of perforation and device expulsion: results from the Association of Perforation and Expulsion of Intrauterine Device study. American Journal of Obstetrics and Gynecology. 2022;227(1):57.e1-57.e13. doi:https://doi.org/10.1016/j.ajog.2022.03.062.
8) Hunter TA, Sonalkar S, Schreiber CA, Perriera LK, Sammel MD, Akers AY. Anticipated Pain During Intrauterine Device Insertion. Journal of Pediatric and Adolescent
9) Kaiser Family Foundation. Intrauterine Devices (IUDs): Access for Women in the U.S. https://www.kff.org/womens-health-policy/fact-sheet/intrauterine-devices-iuds-access-for-women-in-the-u-s. September 9, 2020. Accessed March 19, 2024.
10) Kornides ML, Kitsantas P, Lindley LL, Wu H. Factors Associated with Young Adults’ Pregnancy Likelihood. Journal of Midwifery & Women’s Health. 2015;60(2):158-168. doi:https://doi.org/10.1111/jmwh.12258.
11) Lanzola EL, Ketvertis K. Intrauterine Device. Treasure Island, FL: StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK557403. Accessed March 19, 2024.
12) Mirena® (levonorgestrel-releasing intrauterine system). https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021225s019lbl.pdf. Accessed March 19, 2024.
13) O’Brien K, Russell C, Frances Fei Y, Rosen MW. Use of Two Levonorgestrel Intrauterine Devices in a Patient with a Uterus Didelphys: A Case Report. Journal of Pediatric and Adolescent Gynecology. 2022;35(6):718-721. doi:https://doi.org/10.1016/j.jpag.2022.07.009.
14) Paraguard® T380A intrauterine copper contraceptive. https://www.paragard.com/pdf/PARAGARD-PI.pdf. Accessed March 19, 2024.
15) Secura GM, Allsworth JE, Madden T, Mullersman JL, Peipert JF. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. American Journal of Obstetrics and Gynecology. 2010;203(2):115.e1-115.e7. doi:https://doi.org/10.1016/j.ajog.2010.04.017.
16) Vranic E, Delic T. Intrauterine Devices - Past, present, and future perspectives. Farmacevtski Vestnik. 2006;57(1):14-23. https://www.dlib.si/details/URN:NBN:SI:DOC-XJZ8XJU9. Accessed March 19, 2024.
Volume 07 Issue 05 May 2024
There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 07 Issue 07 (July 2024).
PUBLICATION DATES:
1) Last Date of Submission : 26 July 2024 .
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.